Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention
Authors
Keywords
-
Journal
CELL CYCLE
Volume 17, Issue 3, Pages 356-361
Publisher
Informa UK Limited
Online
2017-11-30
DOI
10.1080/15384101.2017.1405195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma
- (2017) Robert Hoffman INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
- (2017) Kei Kawaguchi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management
- (2017) Andrzej T Slominski et al. LABORATORY INVESTIGATION
- Recombinant methioninase effectively targets a Ewing’s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
- (2017) Takashi Murakami et al. Oncotarget
- Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
- (2017) Kei Kawaguchi et al. Oncotarget
- Is DNA methylation the new guardian of the genome?
- (2017) Robert M. Hoffman Molecular Cytogenetics
- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model
- (2016) Mako Yamamoto et al. PLoS One
- Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
- (2016) Takashi Murakami et al. Oncotarget
- Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model
- (2016) Takashi Murakami et al. Oncotarget
- Melanin content in melanoma metastases affects the outcome of radiotherapy
- (2016) Anna A. Brożyna et al. Oncotarget
- High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model
- (2016) Tasuku Kiyuna et al. Oncotarget
- Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern
- (2015) Yukihiko Hiroshima et al. PLoS One
- Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice
- (2015) Yukihiko Hiroshima et al. PLoS One
- Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
- (2015) Pasha Apontes et al. Oncotarget
- Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models
- (2015) Yukihiko Hiroshima et al. Oncotarget
- Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey
- (2014) Robert M Hoffman EXPERT OPINION ON BIOLOGICAL THERAPY
- Southwest Oncology Group S0008: A Phase III Trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine, Plus Interleukin-2 and Interferon in Patients With High-Risk Melanoma—An Intergroup Study of Cancer and Leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
- (2014) Lawrence E. Flaherty et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-CEA Antibody and a Portable Imaging System
- (2014) Yukihiko Hiroshima et al. Journal of Laparoendoscopic & Advanced Surgical Techniques
- Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer
- (2014) Yukihiko Hiroshima et al. JOURNAL OF SURGICAL ONCOLOGY
- Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates
- (2014) Andrzej T. Slominski et al. MAYO CLINIC PROCEEDINGS
- Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore
- (2014) Yukihiko Hiroshima et al. PLoS One
- Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model
- (2013) Cristina A. Metildi et al. JOURNAL OF SURGICAL ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search